日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta-analysis of randomized clinical trials

非小细胞肺癌患者(PD-L1高表达)对PD-1或PD-L1抑制剂治疗的反应存在性别差异。一项随机临床试验的系统评价和荟萃分析

Conforti, F; Pala, L; Pagan, E; Corti, C; Bagnardi, V; Queirolo, P; Catania, C; De Pas, T; Giaccone, G

1260MO Activity of OSE-2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (ICI): Step 1 results of phase III ATALANTE-1 randomised trial

1260MO OSE-2101 在 HLA-A2+ 非小细胞肺癌 (NSCLC) 患者中免疫检查点抑制剂 (ICI) 治疗失败后的活性:III 期 ATALANTE-1 随机试验的第一阶段结果

Pradier, A; Mamez, A C; Stephan, C; Giannotti, F; Masouridi-Levrat, S; Wang, S; Morin, S; Neofytos, D; Vu, D L; Melotti, A; Arm, I; Eberhardt, C S; Tamburini, J; Kaiser, L; Chalandon, Y; Simonetta, F; Bakouny, Z; Grover, P; Labaki, C; Awosika, J; Gulati, S; Hsu, C-Y; Bilen, MA; Eton, O; Fecher, L; Hwang, C; Khan, H; McKay, RR; Ruiz, E; Weissmann, L; Thompson, MA; Shah, D; Warner, J; Shyr, Y; Choueiri, TK; Wise-Draper, T; Pacheco-Barcia, V; Sanchez, DA; Obispo, B; Quilez, A; Sesma, A; JimEnez Labaig, P; Paez, D; Quintanar Verduguez, T; Sánchez Cánovas, M; Tarazona, N; Fernandez Montes, A; Felip, E; Rodríguez-Lescure, A; Elez Fernandez, ME; Giaccone, G; Felip, E; Cobo, M; Campelo, R Garcia; DENIS, F; Quoix, E; Madroszyk, A; Debieuvre, D; Hilgers, W; Moran, T; Galetta, D; Romano, GD; Cappuzzo, F; Robinet, G; Masson, P; Viteri, S; Peled, N; Costantini, D; Dziadziuszko, R; Besse, B

Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancer

一项随机II期研究,比较吉西他滨联合顺铂治疗晚期食管胃癌患者,并评估补充维生素的疗效。

van Zweeden, A A; van Groeningen, C J; Honeywell, R J; Giovannetti, E; Ruijter, R; Smorenburg, C H; Giaccone, G; Verheul, H M W; Peters, G J; van der Vliet, Hans J

First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors

针对HER2阳性晚期实体瘤患者的margetuximab(MGAH22,一种Fc修饰的嵌合单克隆抗体)的首次人体I期研究

Bang, Y J; Giaccone, G; Im, S A; Oh, D Y; Bauer, T M; Nordstrom, J L; Li, H; Chichili, G R; Moore, P A; Hong, S; Stewart, S J; Baughman, J E; Lechleider, R J; Burris, H A

Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer

Selumetinib联合或不联合厄洛替尼治疗KRAS突变型和KRAS野生型晚期非小细胞肺癌

Carter, C A; Rajan, A; Keen, C; Szabo, E; Khozin, S; Thomas, A; Brzezniak, C; Guha, U; Doyle, L A; Steinberg, S M; Xi, L; Raffeld, M; Tomita, Y; Lee, M J; Lee, S; Trepel, J B; Reckamp, K L; Koehler, S; Gitlitz, B; Salgia, R; Gandara, D; Vokes, E; Giaccone, G

Why has active immunotherapy not worked in lung cancer?

为什么主动免疫疗法在肺癌治疗中无效?

Thomas, A; Giaccone, G

Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumors

以 HER2 异常作为肺癌可操作的驱动因素:泛 HER 酪氨酸激酶抑制剂达可替尼治疗 HER2 突变或扩增肿瘤患者的 II 期试验

Kris, M G; Camidge, D R; Giaccone, G; Hida, T; Li, B T; O'Connell, J; Taylor, I; Zhang, H; Arcila, M E; Goldberg, Z; Jänne, P A

LAMC2 enhances the metastatic potential of lung adenocarcinoma

LAMC2增强肺腺癌的转移潜能

Moon, Y W; Rao, G; Kim, J J; Shim, H-S; Park, K-S; An, S S; Kim, B; Steeg, P S; Sarfaraz, S; Changwoo Lee, L; Voeller, Donna; Choi, E Y; Luo, Ji; Palmieri, D; Chung, H C; Kim, J-H; Wang, Y; Giaccone, G

A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer

一项针对晚期非小细胞肺癌患者的I/II期研究,评估了塞潘曲尼溴化物(YM155,survivin抑制剂)联合紫杉醇和卡铂的疗效。

Kelly, R J; Thomas, A; Rajan, A; Chun, G; Lopez-Chavez, A; Szabo, E; Spencer, S; Carter, C A; Guha, U; Khozin, S; Poondru, S; Van Sant, C; Keating, A; Steinberg, S M; Figg, W; Giaccone, G

From targets to targeted therapies and molecular profiling in non-small cell lung carcinoma

从靶点到靶向治疗以及非小细胞肺癌的分子谱分析

Thomas, A; Rajan, A; Lopez-Chavez, A; Wang, Y; Giaccone, G